Business Description
Prostalund AB
ISIN : SE0023468418
Total Employee Number:
6Compare
Compare
Traded in other countries / regions
7PL0.GermanyPLUN.Sweden IPO Date
2020-08-03Description
Prostalund AB develops, markets and sells urological products. The Company has a treatment concept (CoreTherm Concept) for personalized heat treatment for the condition benign prostatic hyperplasia, also known as BPH or BPE, which mainly affects men over the age of 50. It has developed a new platform, CoreTherm Eagle which includes an inbuilt computer, real-time temperature reading, patient data storage and inbuilt recommendations for treating physicians.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.21 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.32 | |||||
Beneish M-Score | -3.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -75.6 | |||||
3-Year EBITDA Growth Rate | 62.8 | |||||
3-Year EPS without NRI Growth Rate | -2.4 | |||||
3-Year FCF Growth Rate | 67.1 | |||||
3-Year Book Growth Rate | -16.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 43.67 | |||||
9-Day RSI | 44.36 | |||||
14-Day RSI | 44.69 | |||||
3-1 Month Momentum % | 293.75 | |||||
6-1 Month Momentum % | -95 | |||||
12-1 Month Momentum % | 293.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.07 | |||||
Quick Ratio | 0.43 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 1201.33 | |||||
Days Sales Outstanding | 54.95 | |||||
Days Payable | 388.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -38.2 | |||||
Shareholder Yield % | -80.53 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.12 | |||||
Operating Margin % | -167.16 | |||||
Net Margin % | -169.26 | |||||
EBITDA Margin % | -167.05 | |||||
FCF Margin % | -185.74 | |||||
OCF Margin % | -150.83 | |||||
ROE % | -40.11 | |||||
ROA % | -34.84 | |||||
ROIC % | -40.82 | |||||
3-Year ROIIC % | -55.72 | |||||
ROC (Joel Greenblatt) % | -178.62 | |||||
ROCE % | -38.84 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.07 | |||||
PB Ratio | 0.14 | |||||
Price-to-Tangible-Book | 0.74 | |||||
EV-to-EBIT | -0.45 | |||||
EV-to-EBITDA | -0.45 | |||||
EV-to-Revenue | 0.76 | |||||
EV-to-FCF | -0.41 | |||||
Price-to-GF-Value | 0.03 | |||||
Price-to-Median-PS-Value | 0.02 | |||||
| Price-to-Net-Current-Asset-Value | 0.93 | |||||
Earnings Yield (Greenblatt) % | -222.22 | |||||
FCF Yield % | -336.27 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prostalund AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.08 | ||
| EPS (TTM) (€) | -0.508 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.91 | ||
| 3-Year Sortino Ratio | 35.83 | ||
| Volatility % | 7601.25 | ||
| 14-Day RSI | 44.69 | ||
| 14-Day ATR (€) | 0.011586 | ||
| 20-Day SMA (€) | 0.008725 | ||
| 12-1 Month Momentum % | 293.75 | ||
| 52-Week Range (€) | 0.0005 - 1 | ||
| Shares Outstanding (Mil) | 31.12 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Prostalund AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Prostalund AB Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-06 | In 125 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 125 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-21 | In 48 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 48 days | ||
| General meeting for 2026 | 2026-06-25 14:00 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-06-03 | 0.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-29 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-29 | 0.00 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-25 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-25 | 0.00 (+0.00%) |
Show
Entries
Prostalund AB Frequently Asked Questions
What is Prostalund AB(FRA:7PL0)'s stock price today?
The current price of FRA:7PL0 is €0.00. The 52 week high of FRA:7PL0 is €1.00 and 52 week low is €0.00.
When is next earnings date of Prostalund AB(FRA:7PL0)?
The next earnings date of Prostalund AB(FRA:7PL0) is 2026-08-21 Est..
Does Prostalund AB(FRA:7PL0) pay dividends? If so, how much?
Prostalund AB(FRA:7PL0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Prostalund AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers